Showing 211-220 of 2478 results for "".
In Epilepsy Care, Non-pharmacologic Research Takes Center Stage
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/in-epilepsy-care-non-pharmacologic-research-takes-center-stage/30602/Researchers say minimally invasive surgeries, alternative interventions, and new genetic findings are the top stories of 2014.Special Report: AAN Annual Meeting: Video Coverage, Study Highlights, and More
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/special-report-aan-annual-meeting-video-coverage-study-highlights-and-more/30458/Amyotrophic Lateral Sclerosis with Atrophy of the Amygdala
https://practicalneurology.com/diseases-diagnoses/neuromuscular/amyotrophic-lateral-sclerosis-with-atrophy-of-the-amygdala/30444/Early and pronounced involvement of the amygdala is known to be characteristic for the behavioral variant of frontotemporal dementia, but it may also occur in ALS.Obstructive Sleep Apnea and Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/obstructive-sleep-apnea-and-epilepsy/30251/It is important to consider comorbid sleep disorders for patients with epilepsy.An Update on Antiplatelet Therapy for Secondary Stroke Prevention
https://practicalneurology.com/diseases-diagnoses/stroke/PN0809_03-php/30895/Recent data on stroke, insights from other specialties, and developments in the antiplatelet arena may influence management of stroke patients.Multiple Sclerosis: In-Focus
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-focus/30519/Mood Disorders Following Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/mood-disorders-following-traumatic-brain-injury/31994/Update on mood disorders, including depressive disorder and anxiety disorders along with accompanying symptoms, following TBIAntisense Oligonucleotide Therapies
https://practicalneurology.com/diseases-diagnoses/movement-disorders/antisense-oligonucleotide-therapies/31573/Antisense oligonucleotides are a promising new therapeutic class being studied for the treatment of movement disorders.A Coming of Age for Neuroimmunology
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/a-coming-of-age-for-neuroimmunology/30122/Increasingly complex diagnostics and highly effective disease-modifying therapy come with challenges in clinical decision making.Paramyotonia Congenita and HypoKPP
https://practicalneurology.com/diseases-diagnoses/neuromuscular/paramyotonia-congenita-and-hypokpp/30479/